Narrative review / 2013
Urinary PGE-M is associated with obesity, smoking, lung metastases, and breast cancer risk, suggesting utility as a cancer biomarker.
This commentary discusses the potential of inflammatory biomarkers in cancer risk prediction and disease progression. Morris and colleagues reported that urinary PGE-M was positively associated with obesity, smoking, and lung metastases in breast cancer patients. Additionally, Kim and colleagues identified a potential association between urinary PGE-M and breast cancer risk among postmenopausal women, supporting urinary PGE-M as a promising biomarker.
Shows an association, not proof of cause and effect.
- Study type
- Commentary / narrative review
- Who was studied
- Patients with breast cancer and postmenopausal women
- What was measured
- Cancer risk, disease progression, obesity, smoking, and lung metastases
THE PAPER
Urinary PGE-M: a promising cancer biomarker.
Wang D, DuBois RN. Cancer Prev Res (Phila), 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.